Joinn Labs extends key lease, plans wealth management and related party deals

On December 5, 2025, Joinn Laboratories (China) announced a connected transaction to extend its Biorichland lease until December 31, 2028. This follows previous extensions from a 2021 agreement for property in Richmond, CA, with annual rents increasing by 3% for the premises ($60,916.00 in 2026) and a fixed monthly rent for equipment ($2,226.33). The transaction is subject to reporting and announcement requirements.

Concurrently, the company's board of directors approved forecasts for 2026, including up to RMB 2 billion in entrusted wealth management for idle funds. They also approved an estimated RMB 47m in daily connected transactions with Sutaishen (Beijing) Bio-pharmaceutical Co., Ltd. and its subsidiaries for non-clinical and clinical R&D outsourcing services. Furthermore, Joinn Laboratories (China) is set to engage in related party transactions for "digital intelligence services" with Shengcong Intelligent Technology (Beijing) Co., Ltd., totaling no more than RMB 16.5m for 2026. These transactions, approved by the board and independent directors, are deemed to be in the company's and its shareholders' best interests.